Summary

Global digital pathology market is expected to grow at a formidable rate during the forecast period. The global digital pathology market is driven by the increasing prevalence of diseases especially chronic diseases such as cancer, diabetes, renal diseases, cancer, hepatitis, among others. This has drastically increased the number of patients suffering from these diseases, thereby increasing the need to adopt digital methods of diagnosis which increase the efficiency of diagnosis thereby driving the growth of market. Furthermore, increasing expenditure by the key vendors operating in the industry on laboratory expansion and enhancement is anticipated to positively impact the growth of market over the next few years.

The global digital pathology market is segmented based on component, technology, type, application, end user, company and region. Based on component, the market can be categorized into software, scanner and services. The software segment is expected to register the highest growth during forecast period owing to the availability of user friendly software with analytical and advanced functions for pathology diagnosis. Based on application, the market can be grouped into drug discovery, disease diagnosis, teleconsultation, training & education and others. The drug discovery segment is expected to dominate the market through 2025. This can be ascribed to the growing R&D expenditure by the major players operating in the market on account of the increasing need for numerous preclinical and clinical studies for drug discovery process. Based on end user, the market can be fragmented into hospitals & clinics, biotechnology & pharmaceutical companies, research laboratories, contract research organizations and others. The hospitals & clinics segment is expected to dominate the market over the next few years owing to the increase in the number of hospitals & clinics incorporating this technique of diagnostics over the conventional ones.

Regionally, the digital pathology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall digital pathology market owing to the growing prevalence of chronic diseases in the region. Additionally, favorably reimbursement policies and government support & initiatives are further anticipated to propel the growth of market in the region.

Major players operating in the global digital pathology market include Leica Biosystems, Koninklijke Philips N.V., Hamamatsu Photonics, F. Hoffmann-La Roche AG, 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Huron Digital Pathology, Visiopharm A/S, Corista, Indica Labs, Objective Pathology Services, Sectra AB, OptraSCAN, Glencoe Software, KONFOONG BIOTECH INTERNATIONAL CO., LTD, Inspirata, Inc., Mikroscan Technologies, Proscia Inc., Kanteron Systems and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the Study:
• To analyze and estimate the market size of global digital pathology market from 2015 to 2018.
• To estimate and forecast the market size of global digital pathology market from 2019 to 2025 and growth rate until 2025.
• To classify and forecast global digital pathology market based component, technology, type, application, end user, company and regional distribution.
• To identify dominant region or segment in the global digital pathology market.
• To identify drivers and challenges for global digital pathology market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global digital pathology market.
• To identify and analyze the profile of leading players operating in global digital pathology market.
• To identify key sustainable strategies adopted by market players in global digital pathology market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global digital pathology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Digital pathology service providers, vendors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to digital pathology
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global digital pathology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Global Digital Pathology Market, By Component:
o Software
 Image Analysis Platform
 DPIS
 Others
o Scanner
 Brightfield Scanner
 Fluorescence Scanner
o Services
 Installation & Integration
 Consulting
 Maintenance
• Global Digital Pathology Market, By Technology:
o Whole Slide Imaging
o Storage
o Communication & Integrated Platforms
o Image Analysis-Informatics
o Others
• Global Digital Pathology Market, By Type:
o Human
o Veterinary
• Global Digital Pathology Market, By Application:
o Drug Discovery
o Disease Diagnosis
o Teleconsultation
o Training & Education
o Other
• Global Digital Pathology Market, By End User:
o Hospitals & Clinics
o Biotechnology & Pharmaceutical Companies
o Research Laboratories
o Contract Research Organizations
o Others
• Global Digital Pathology Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 Japan
 India
 South Korea
 Australia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Kuwait
o South America
 Brazil
 Argentina
 Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global digital pathology market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Digital Pathology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Software, Scanner, Services)
5.2.1.1. By Software (Image Analysis Platform, DPIS, Others)
5.2.1.2. By Scanner (Brightfield Scanner v/s Fluorescence Scanner)
5.2.1.3. By Services (Installation & Integration, Consulting, Maintenance)
5.2.2. By Technology (Whole Slide Imaging, Storage, Communication & Integrated Platforms, Image Analysis-Informatics, Others)
5.2.3. By Type (Human v/s Veterinary)
5.2.4. By Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education, Others)
5.2.5. By End Users (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Research Laboratories, Contract Research Organizations, Others)
5.2.6. By Company (2019)
5.2.7. By Region
5.3. Product Market Map
6. Asia-Pacific Digital Pathology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Technology
6.2.3. By Type
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Digital Pathology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Type
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. India Digital Pathology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Type
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Australia Digital Pathology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Type
6.3.3.2.3. By Application
6.3.3.2.4. By End User
6.3.4. Japan Digital Pathology Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technology
6.3.4.2.2. By Type
6.3.4.2.3. By Application
6.3.4.2.4. By End User
6.3.5. South Korea Digital Pathology Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technology
6.3.5.2.2. By Type
6.3.5.2.3. By Application
6.3.5.2.4. By End User
7. Europe Digital Pathology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Technology
7.2.3. By Type
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Digital Pathology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Type
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Germany Digital Pathology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Type
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Digital Pathology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Type
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Digital Pathology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Type
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Digital Pathology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Type
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. North America Digital Pathology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Technology
8.2.3. By Type
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. North America: Country Analysis
8.3.1. United States Digital Pathology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Type
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. Mexico Digital Pathology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Type
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Canada Digital Pathology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Type
8.3.3.2.3. By Application
8.3.3.2.4. By End User
9. South America Digital Pathology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Technology
9.2.3. By Type
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Digital Pathology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Type
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Digital Pathology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Type
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Digital Pathology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Type
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Digital Pathology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Technology
10.2.3. By Type
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Digital Pathology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Type
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Digital Pathology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Type
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Digital Pathology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Type
10.3.3.2.3. By Application
10.3.3.2.4. By End User
10.3.4. Kuwait Digital Pathology Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Technology
10.3.4.2.2. By Type
10.3.4.2.3. By Application
10.3.4.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Leica Biosystems
13.2. Koninklijke Philips N.V.
13.3. Hamamatsu Photonics
13.4. F. Hoffmann-La Roche AG
13.5. 3DHISTECH
13.6. Apollo Enterprise Imaging
13.7. XIFIN
13.8. Huron Digital Pathology
13.9. Visiopharm A/S
13.10. Corista
13.11. Indica Labs
13.12. Objective Pathology Services
13.13. Sectra AB
13.14. OptraSCAN
13.15. Glencoe Software
13.16. KONFOONG BIOTECH INTERNATIONAL CO., LTD
13.17. Inspirata, Inc.
13.18. Mikroscan Technologies
13.19. Proscia Inc.
13.20. Kanteron Systems
14. Strategic Recommendations
15. About Us & Disclaimer